IMMURON LIMITED - Announcements

Market Cap $20.52M Add to my watchlist

Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).More

Announcements

Filter Results

All Price Sensitive Only

IMC	Appendix 3B - Exercise of Options		19/10/15	148.93KB	Share
IMC	Appendix 3B - Exercise of Options		30/09/15	583.57KB	Share
IMC	Appendix 3B - Exercise of Options		18/09/15	149.16KB	Share
IMC	Change of Director's Interest Notice - (PA)		10/09/15	248.43KB	Share
IMC	Immuron is Now US OTCQB Listed		10/09/15	78.47KB	Share
IMC	Red Chip Interview with Immuron Vice Chairman		08/09/15	64.84KB	Share
IMC	Immuron Applies for US OTCQB Listing		01/09/15	65.15KB	Share
IMC	Appendix 4E Preliminary Final Report & Annual Report	PRICE SENSITIVE	28/08/15	3.5MB	Share
IMC	Appendix 4G - Corporate Governance		28/08/15	274.44KB	Share
IMC	Peter Anastasiou Appointed Vice Chairman		27/08/15	80.94KB	Share
IMC	Immuron Appoints New Chief Executive Officer	PRICE SENSITIVE	25/08/15	95.52KB	Share
IMC	Red Chip Analyst Report		20/08/15	67.47KB	Share
IMC	Immuron Commences US Investor Roadshow Presentation		19/08/15	3.69MB	Share
IMC	Shareholder Newsletter - August 2015		18/08/15	362.1KB	Share
IMC	Proposed Issue of Unlisted Options	PRICE SENSITIVE	06/08/15	70.16KB	Share
IMC	Immuron Executes Major US Travelan Sales Agreement	PRICE SENSITIVE	04/08/15	99.83KB	Share
IMC	Immuron Appoints Chief Operating & Scientific Officer		28/07/15	82.06KB	Share
IMC	Resignation of Chief Executive Officer	PRICE SENSITIVE	08/07/15	82.13KB	Share
IMC	NASH Clinical Trial Update - Patient Recruitment Advances	PRICE SENSITIVE	02/07/15	90.52KB	Share
IMC	Appendix 3Y - Change of Director's Interest Notice (DP)		23/06/15	43.78KB	Share
IMC	Immuron Appoints Senior Vice President of Innovation		11/06/15	94.04KB	Share
IMC	Appendix 3Y - Change of Director's Interest Notice (PA)		27/05/15	44.04KB	Share
IMC	Appendix 3X - Initial Director's Interest Notice (PA)		21/05/15	38.21KB	Share
IMC	Immuron Appoints New Director - Mr Peter Anastasiou		21/05/15	95.56KB	Share
IMC	IMMURON ANNOUNCES FIRST USA ORDERS FOR TRAVELAN	PRICE SENSITIVE	20/04/15	102.54KB	Share
IMC	Immuron Appoints Dr. Leearne Hinch as New CEO	PRICE SENSITIVE	02/04/15	74.35KB	Share
IMC	Appendix 4D - Half Yearly Report and Accounts	PRICE SENSITIVE	18/02/15	765.31KB	Share
IMC	Marketing and Distribution Agreement signed for China	PRICE SENSITIVE	17/02/15	82.72KB	Share
IMC	Patient Recruitment Commenced for Phase 2 NASH Trial	PRICE SENSITIVE	03/02/15	98.72KB	Share
IMC	Patient Recruitment Commenced for Phase 2 ASH Trial		15/01/15	110.21KB	Share
IMC	IMC signs License Agreement for Development for Alcohol Tox	PRICE SENSITIVE	06/01/15	78.39KB	Share
IMC	Resignation of CEO	PRICE SENSITIVE	18/12/14	80.47KB	Share
IMC	Ethics Approval Secured in all Australian NASH Trial Sites		27/11/14	82.85KB	Share
IMC	Immuron to Recommence Trading as IMC		27/11/14	72.14KB	Share
IMC	Appendix 3B and 708A		21/11/14	174.98KB	Share
IMC	Immuron Completes Capital Consolidation	PRICE SENSITIVE	20/11/14	86.3KB	Share
IMC	Results of Annual General Meeting		13/11/14	78.73KB	Share
IMC	2014 Annual General Meeting CEO Presentation		13/11/14	2.28MB	Share
IMC	NASH & ASH Clinical Trial Update	PRICE SENSITIVE	15/10/14	128.94KB	Share
IMC	Notice of Annual General Meeting - 13 Nov 2014		14/10/14	457.56KB	Share
IMC	Immuron Improves Hadasit Royalty Terms	PRICE SENSITIVE	02/09/14	73.79KB	Share
IMC	Appendix 4E Preliminary Final Report and Statutory Accounts	PRICE SENSITIVE	29/08/14	2.36MB	Share
IMC	Paladin Labs Announces the Launch of Travelan in Canada	PRICE SENSITIVE	06/08/14	416.14KB	Share
IMC	Immuron CEO Presents at 2014 Bioshares Biotech Summit		21/07/14	3.72MB	Share
IMC	Immuron FY2014 Travelan Sales Exceed $1m	PRICE SENSITIVE	07/07/14	75.14KB	Share
IMC	Notice to Unmarketable Parcel Shareholders - Sale Facility		04/07/14	650.28KB	Share
IMC	IMC CEO Presentation to 2014 Asia Biotech Invest Conference		05/06/14	2.86MB	Share
IMC	Immuron to present at 2014 Asia Biotech Invest Conference		03/06/14	265.1KB	Share
IMC	Appendix 3Y - Change of Director's Interest Notice (SA)		29/05/14	44.38KB	Share
IMC	Appendix 3B		29/05/14	177.5KB	Share
IMC	Update Constitution - May 2014		27/05/14	288.1KB	Share
IMC	Results of General Meeting		27/05/14	82.76KB	Share
IMC	Immuron Signs Agreement to Sell Travelan in South Korea	PRICE SENSITIVE	21/05/14	119.38KB	Share
IMC	Immuron Extinguishes Paladin Debt	PRICE SENSITIVE	05/05/14	71.94KB	Share
IMC	Notice of General Meeting		28/04/14	313.6KB	Share
IMC	Shareholder Update - April 2014		03/04/14	591.78KB	Share
IMC	604 Change of Substantial Shareholder Interest (Grandlodge)		05/03/14	44.04KB	Share
IMC	Appendix 3Y-Chng of Director's Interest Notice x3 (RA,DP,SA)		05/03/14	135.02KB	Share
IMC	Top 20 Holder Report for IMC Fully Paid Ordinary Shares		03/03/14	132.04KB	Share
IMC	Appendix 3B		03/03/14	178.91KB	Share
IMC	Appendix 4D and Interim Financial Report - Dec 2013	PRICE SENSITIVE	28/02/14	1.21MB	Share
IMC	Renounceable Rights Issue - Closure, Acceptances & Shortfall	PRICE SENSITIVE	26/02/14	78.95KB	Share
IMC	Appendix 3B - Exercise of IMCOA		03/02/14	154.59KB	Share
IMC	Change of Substantial Shareholder Notice (Grandlodge)		29/01/14	180.95KB	Share
IMC	Ceasing to be a Substantial Shareholder (Texas Woods)		29/01/14	37.6KB	Share
IMC	Letter to Immuron Shareholders - Rights Issue		24/01/14	116.59KB	Share
IMC	Letter to Immuron Optionholders - Rights Issue		23/01/14	108.59KB	Share
IMC	Offer Document for $9.66M Fully Underwritten Rights Issue		23/01/14	427.23KB	Share
IMC	Section 708A Notice		23/01/14	126.38KB	Share
IMC	Immuron Investor Presentation - January 2014		22/01/14	6.92MB	Share
IMC	Appendix 3B - Fully Underwritten Rights Issue		22/01/14	165.97KB	Share
IMC	Immuron to Raise $9.66M via Fully Underwritten Rights Issue	PRICE SENSITIVE	22/01/14	102.11KB	Share
IMC	Trading Halt Request		20/01/14	67.96KB	Share
IMC	Trading Halt	PRICE SENSITIVE	20/01/14	78.62KB	Share
IMC	Change of Share Registry Service Provider		07/01/14	97.35KB	Share
IMC	Appendix 3Y's - Change of Director's Interest Notice (x3)		05/12/13	138.11KB	Share
IMC	Appendix 3B		04/12/13	220.55KB	Share
IMC	Results of 2013 Annual General Meeting		29/11/13	227.69KB	Share
IMC	Results of Meeting		29/11/13	227.69KB	Share
IMC	2013 Annual General Meeting CEO Presentation		29/11/13	981.51KB	Share
IMC	Ceasing to be Substantial S/H (Capital Concerns) AMENDED		19/11/13	257.52KB	Share
IMC	Ceasing to be a substantial holder		13/11/13	262.47KB	Share
IMC	Immuron's Travelan Approved for Marketing in Canada	PRICE SENSITIVE	13/11/13	84.88KB	Share
IMC	US FDA Clears Another IND for Phase 2 Trial for IMM-124E	PRICE SENSITIVE	08/11/13	141.85KB	Share
IMC	Fibrosis Results Presented at International Conference		07/11/13	119.69KB	Share
IMC	2013 Notice of Annual General Meeting		30/10/13	646.11KB	Share
IMC	Form 603 - Becoming a Substantial SH (Inverarey PL)		23/10/13	230.23KB	Share
IMC	Immuron Allowed Travelan Patent in the United States	PRICE SENSITIVE	23/10/13	81.35KB	Share
IMC	2013 Annual Report to Shareholders		27/09/13	3.75MB	Share
IMC	Appendix 3Z - Final Director's Interest Notice (EZ)		02/09/13	36.55KB	Share
IMC	Retirement of Non-Executive Director Dr Elane Zelcer		02/09/13	93.31KB	Share
IMC	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	30/08/13	1.08MB	Share
IMC	Immuron Shareholder Update - August 2013		05/08/13	463.88KB	Share
IMC	Appendix 3B & 708A Notice		15/07/13	194.63KB	Share
IMC	Change of Registered Office Location		10/07/13	94.15KB	Share
IMC	Form 603 - Becoming a Substantial SH (D.Plush/Texas WoodsPL)		08/07/13	400.43KB	Share
IMC	Appendix 3Z - Final Director's Interest Notice (SW)		03/07/13	36.3KB	Share
IMC	Retirement of Non-Executive Director Dr Stewart Washer		03/07/13	93.29KB	Share
IMC	Change in Substantial Shareholder Notice (Hadasit Medical)		06/06/13	541.57KB	Share
IMC	Immuron to Adopt a New Direct-to-Wholesalers Sales Model	PRICE SENSITIVE	04/06/13	91.71KB	Share

IMC Appendix 3B - Exercise of Options
19/10/15		148.93KB	Share
IMC Appendix 3B - Exercise of Options
30/09/15		583.57KB	Share
IMC Appendix 3B - Exercise of Options
18/09/15		149.16KB	Share
IMC Change of Director's Interest Notice - (PA)
10/09/15		248.43KB	Share
IMC Immuron is Now US OTCQB Listed
10/09/15		78.47KB	Share
IMC Red Chip Interview with Immuron Vice Chairman
08/09/15		64.84KB	Share
IMC Immuron Applies for US OTCQB Listing
01/09/15		65.15KB	Share
IMC Appendix 4E Preliminary Final Report & Annual Report
28/08/15	PRICE SENSITIVE	3.5MB	Share
IMC Appendix 4G - Corporate Governance
28/08/15		274.44KB	Share
IMC Peter Anastasiou Appointed Vice Chairman
27/08/15		80.94KB	Share
IMC Immuron Appoints New Chief Executive Officer
25/08/15	PRICE SENSITIVE	95.52KB	Share
IMC Red Chip Analyst Report
20/08/15		67.47KB	Share
IMC Immuron Commences US Investor Roadshow Presentation
19/08/15		3.69MB	Share
IMC Shareholder Newsletter - August 2015
18/08/15		362.1KB	Share
IMC Proposed Issue of Unlisted Options
06/08/15	PRICE SENSITIVE	70.16KB	Share
IMC Immuron Executes Major US Travelan Sales Agreement
04/08/15	PRICE SENSITIVE	99.83KB	Share
IMC Immuron Appoints Chief Operating & Scientific Officer
28/07/15		82.06KB	Share
IMC Resignation of Chief Executive Officer
08/07/15	PRICE SENSITIVE	82.13KB	Share
IMC NASH Clinical Trial Update - Patient Recruitment Advances
02/07/15	PRICE SENSITIVE	90.52KB	Share
IMC Appendix 3Y - Change of Director's Interest Notice (DP)
23/06/15		43.78KB	Share
IMC Immuron Appoints Senior Vice President of Innovation
11/06/15		94.04KB	Share
IMC Appendix 3Y - Change of Director's Interest Notice (PA)
27/05/15		44.04KB	Share
IMC Appendix 3X - Initial Director's Interest Notice (PA)
21/05/15		38.21KB	Share
IMC Immuron Appoints New Director - Mr Peter Anastasiou
21/05/15		95.56KB	Share
IMC IMMURON ANNOUNCES FIRST USA ORDERS FOR TRAVELAN
20/04/15	PRICE SENSITIVE	102.54KB	Share
IMC Immuron Appoints Dr. Leearne Hinch as New CEO
02/04/15	PRICE SENSITIVE	74.35KB	Share
IMC Appendix 4D - Half Yearly Report and Accounts
18/02/15	PRICE SENSITIVE	765.31KB	Share
IMC Marketing and Distribution Agreement signed for China
17/02/15	PRICE SENSITIVE	82.72KB	Share
IMC Patient Recruitment Commenced for Phase 2 NASH Trial
03/02/15	PRICE SENSITIVE	98.72KB	Share
IMC Patient Recruitment Commenced for Phase 2 ASH Trial
15/01/15		110.21KB	Share
IMC IMC signs License Agreement for Development for Alcohol Tox
06/01/15	PRICE SENSITIVE	78.39KB	Share
IMC Resignation of CEO
18/12/14	PRICE SENSITIVE	80.47KB	Share
IMC Ethics Approval Secured in all Australian NASH Trial Sites
27/11/14		82.85KB	Share
IMC Immuron to Recommence Trading as IMC
27/11/14		72.14KB	Share
IMC Appendix 3B and 708A
21/11/14		174.98KB	Share
IMC Immuron Completes Capital Consolidation
20/11/14	PRICE SENSITIVE	86.3KB	Share
IMC Results of Annual General Meeting
13/11/14		78.73KB	Share
IMC 2014 Annual General Meeting CEO Presentation
13/11/14		2.28MB	Share
IMC NASH & ASH Clinical Trial Update
15/10/14	PRICE SENSITIVE	128.94KB	Share
IMC Notice of Annual General Meeting - 13 Nov 2014
14/10/14		457.56KB	Share
IMC Immuron Improves Hadasit Royalty Terms
02/09/14	PRICE SENSITIVE	73.79KB	Share
IMC Appendix 4E Preliminary Final Report and Statutory Accounts
29/08/14	PRICE SENSITIVE	2.36MB	Share
IMC Paladin Labs Announces the Launch of Travelan in Canada
06/08/14	PRICE SENSITIVE	416.14KB	Share
IMC Immuron CEO Presents at 2014 Bioshares Biotech Summit
21/07/14		3.72MB	Share
IMC Immuron FY2014 Travelan Sales Exceed $1m
07/07/14	PRICE SENSITIVE	75.14KB	Share
IMC Notice to Unmarketable Parcel Shareholders - Sale Facility
04/07/14		650.28KB	Share
IMCIMC CEO Presentation to 2014 Asia Biotech Invest Conference
05/06/14		2.86MB	Share
IMCImmuron to present at 2014 Asia Biotech Invest Conference
03/06/14		265.1KB	Share
IMCAppendix 3Y - Change of Director's Interest Notice (SA)
29/05/14		44.38KB	Share
IMCAppendix 3B
29/05/14		177.5KB	Share
IMCUpdate Constitution - May 2014
27/05/14		288.1KB	Share
IMCResults of General Meeting
27/05/14		82.76KB	Share
IMCImmuron Signs Agreement to Sell Travelan in South Korea
21/05/14	PRICE SENSITIVE	119.38KB	Share
IMCImmuron Extinguishes Paladin Debt
05/05/14	PRICE SENSITIVE	71.94KB	Share
IMCNotice of General Meeting
28/04/14		313.6KB	Share
IMCShareholder Update - April 2014
03/04/14		591.78KB	Share
IMC604 Change of Substantial Shareholder Interest (Grandlodge)
05/03/14		44.04KB	Share
IMCAppendix 3Y-Chng of Director's Interest Notice x3 (RA,DP,SA)
05/03/14		135.02KB	Share
IMCTop 20 Holder Report for IMC Fully Paid Ordinary Shares
03/03/14		132.04KB	Share
IMCAppendix 3B
03/03/14		178.91KB	Share
IMCAppendix 4D and Interim Financial Report - Dec 2013
28/02/14	PRICE SENSITIVE	1.21MB	Share
IMCRenounceable Rights Issue - Closure, Acceptances & Shortfall
26/02/14	PRICE SENSITIVE	78.95KB	Share
IMCAppendix 3B - Exercise of IMCOA
03/02/14		154.59KB	Share
IMCChange of Substantial Shareholder Notice (Grandlodge)
29/01/14		180.95KB	Share
IMCCeasing to be a Substantial Shareholder (Texas Woods)
29/01/14		37.6KB	Share
IMCLetter to Immuron Shareholders - Rights Issue
24/01/14		116.59KB	Share
IMCLetter to Immuron Optionholders - Rights Issue
23/01/14		108.59KB	Share
IMCOffer Document for $9.66M Fully Underwritten Rights Issue
23/01/14		427.23KB	Share
IMCSection 708A Notice
23/01/14		126.38KB	Share
IMCImmuron Investor Presentation - January 2014
22/01/14		6.92MB	Share
IMCAppendix 3B - Fully Underwritten Rights Issue
22/01/14		165.97KB	Share
IMCImmuron to Raise $9.66M via Fully Underwritten Rights Issue
22/01/14	PRICE SENSITIVE	102.11KB	Share
IMCTrading Halt Request
20/01/14		67.96KB	Share
IMCTrading Halt
20/01/14	PRICE SENSITIVE	78.62KB	Share
IMCChange of Share Registry Service Provider
07/01/14		97.35KB	Share
IMCAppendix 3Y's - Change of Director's Interest Notice (x3)
05/12/13		138.11KB	Share
IMCAppendix 3B
04/12/13		220.55KB	Share
IMCResults of 2013 Annual General Meeting
29/11/13		227.69KB	Share
IMCResults of Meeting
29/11/13		227.69KB	Share
IMC2013 Annual General Meeting CEO Presentation
29/11/13		981.51KB	Share
IMCCeasing to be Substantial S/H (Capital Concerns) AMENDED
19/11/13		257.52KB	Share
IMCCeasing to be a substantial holder
13/11/13		262.47KB	Share
IMCImmuron's Travelan Approved for Marketing in Canada
13/11/13	PRICE SENSITIVE	84.88KB	Share
IMCUS FDA Clears Another IND for Phase 2 Trial for IMM-124E
08/11/13	PRICE SENSITIVE	141.85KB	Share
IMCFibrosis Results Presented at International Conference
07/11/13		119.69KB	Share
IMC2013 Notice of Annual General Meeting
30/10/13		646.11KB	Share
IMCForm 603 - Becoming a Substantial SH (Inverarey PL)
23/10/13		230.23KB	Share
IMCImmuron Allowed Travelan Patent in the United States
23/10/13	PRICE SENSITIVE	81.35KB	Share
IMC2013 Annual Report to Shareholders
27/09/13		3.75MB	Share
IMCAppendix 3Z - Final Director's Interest Notice (EZ)
02/09/13		36.55KB	Share
IMCRetirement of Non-Executive Director Dr Elane Zelcer
02/09/13		93.31KB	Share
IMCAppendix 4E - Preliminary Final Report
30/08/13	PRICE SENSITIVE	1.08MB	Share
IMCImmuron Shareholder Update - August 2013
05/08/13		463.88KB	Share
IMCAppendix 3B & 708A Notice
15/07/13		194.63KB	Share
IMCChange of Registered Office Location
10/07/13		94.15KB	Share
IMCForm 603 - Becoming a Substantial SH (D.Plush/Texas WoodsPL)
08/07/13		400.43KB	Share
IMCAppendix 3Z - Final Director's Interest Notice (SW)
03/07/13		36.3KB	Share
IMCRetirement of Non-Executive Director Dr Stewart Washer
03/07/13		93.29KB	Share
IMCChange in Substantial Shareholder Notice (Hadasit Medical)
06/06/13		541.57KB	Share
IMCImmuron to Adopt a New Direct-to-Wholesalers Sales Model
04/06/13	PRICE SENSITIVE	91.71KB	Share

REFRESH

First 4 5 6 7 8

(20min delay)
Last 9.0¢		Change -0.002(2.17%)		Mkt cap ! $20.52M

Open	High	Low	Value	Volume
9.0¢	9.0¢	9.0¢	$10.8K	120K

Buyers (Bids)

No.	Vol.	Price($)
2	50000	9.0¢

Sellers (Offers)

Price($)	Vol.	No.
9.5¢	1500	2

View Market Depth

No.	Vol.	Price($)
2	50000	0.090
1	31751	0.089
2	233688	0.088
1	9309	0.087
1	6849	0.086

Price($)	Vol.	No.
0.095	1500	2
0.097	1500	2
0.098	5714	1
0.100	119000	4
0.105	140757	6

Last trade - 10.04am 21/05/2024 (20 minute delay)


Last 9.0¢		Change -0.002 ( 1.10 %)
Open	High	Low	Volume
9.1¢	9.1¢	9.0¢	42000
Last updated 11.51am 21/05/2024 ?

IMC (ASX) Chart

IMMURON LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories